[Compromised immune function in multiple myeloma]

Area of Science:

• Infectious Diseases
• Hematology
• Immunology

Context:

• Multiple myeloma patients exhibit heightened susceptibility to bacterial infections, including Streptococcus pneumoniae.
• Prophylactic strategies are crucial to mitigate infection-related morbidity and mortality in these immunocompromised individuals.

Purpose:

• To evaluate the efficacy of sulfamethoxazole-trimethoprim prophylaxis in preventing bacterial infections during initial chemotherapy for multiple myeloma.
• To assess the effectiveness of pneumococcal and influenza vaccinations and the utility of intravenous immunoglobulin in managing infections in multiple myeloma patients.

Summary:

• Oral sulfamethoxazole-trimethoprim administered during the first two months of chemotherapy demonstrated effectiveness in bacterial infection prophylaxis.
• Specific antibody titers for Streptococcus pneumoniae were reduced in patients compared to controls, indicating impaired immune response.
• Pneumococcal and influenza vaccination responses were limited (30-40% for pneumococcal), and intravenous immunoglobulin showed utility for severe infections during the plateau phase.

Impact:

• Sulfamethoxazole-trimethoprim provides a valuable prophylactic option for bacterial infections in newly diagnosed multiple myeloma patients.
• Identifying patients who benefit from interventions like pneumococcal vaccination can be achieved by measuring IgG antibody responses.
• This study informs clinical practice regarding infection prevention strategies in multiple myeloma management.